Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Roche Holding AG
  6. News
  7. Summary
    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
Real-time Estimate Cboe Europe  -  11:05 2022-09-30 am EDT
322.83 CHF   +0.80%
05:41aBiogen: EMA Accepts Application for RoActemra Biosimilar
DJ
09/29ROCHE HOLDINGS AG : UBS reiterates its Neutral rating
MD
09/29ROCHE HOLDINGS AG : Deutsche Bank gives a Neutral rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

ROCHE HOLDINGS AG : Buy rating from Goldman Sachs

07/26/2022 | 04:06am EDT

Keyur Parekh from Goldman Sachs retains his positive opinion on the stock with a Buy rating. The target price is set at 444 versus 445 CHF.


© MarketScreener with dpa-AFX Analyser 2022
All news about ROCHE HOLDING AG
05:41aBiogen: EMA Accepts Application for RoActemra Biosimilar
DJ
09/29ROCHE HOLDINGS AG : UBS reiterates its Neutral rating
MD
09/29ROCHE HOLDINGS AG : Deutsche Bank gives a Neutral rating
MD
09/29ROCHE HOLDINGS AG : Barclays keeps its Buy rating
MD
09/28MarketScreener's World Press Review : September 28, ..
MS
09/28ROCHE HOLDINGS AG : Deutsche Bank reaffirms its Neutral rating
MD
09/28Biogen, Eisai stocks soar on Alzheimer's success, lifting rival shares
RE
09/27Alzheimer's drug study yields positive results, say makers Eisai and Biogen
RE
09/27Eisai says Alzheimer's drug succeeds in slowing cognitive decline
RE
09/26GSK plc - Iain Mackay, Chief Financial Officer, to retire from GSK, Julie Brown appoint..
AQ
More news
Analyst Recommendations on ROCHE HOLDING AG
More recommendations
Financials
Sales 2022 63 959 M 65 272 M 65 272 M
Net income 2022 14 880 M 15 185 M 15 185 M
Net Debt 2022 11 286 M 11 518 M 11 518 M
P/E ratio 2022 17,0x
Yield 2022 3,01%
Capitalization 264 B 269 B 269 B
EV / Sales 2022 4,30x
EV / Sales 2023 4,16x
Nbr of Employees 100 920
Free-Float 89,0%
Chart ROCHE HOLDING AG
Duration : Period :
Roche Holding AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROCHE HOLDING AG
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Last Close Price 320,25 CHF
Average target price 376,25 CHF
Spread / Average Target 17,5%
EPS Revisions
Managers and Directors
Severin Schwan Chief Executive Officer & Executive Director
Alan Hippe Chief Financial & Information Officer
Christoph Franz Chairman
Levi A. Garraway Chief Medical Officer
Pascale Schmidt Chief Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
ROCHE HOLDING AG-15.52%269 089
JOHNSON & JOHNSON-3.82%432 579
ELI LILLY AND COMPANY21.06%313 567
ABBVIE INC.5.41%252 343
PFIZER, INC.-25.22%247 841
NOVO NORDISK A/S4.04%227 444